Corcept Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
Corcept Therapeutics(CORT) stock is priced at $36.92, giving the company a market capitalization of 3.88B. It carries a P/E multiple of 40.32.
During the trading session on 2026-01-21, Corcept Therapeutics(CORT) shares reached a daily high of $37.50 and a low of $34.75. At a current price of $36.92, the stock is +6.2% higher than the low and still -1.5% under the high.
Trading volume for Corcept Therapeutics(CORT) stock has reached 433.63K, versus its average volume of 1.84M.
The stock's 52-week range extends from a low of $32.99 to a high of $117.33.
The stock's 52-week range extends from a low of $32.99 to a high of $117.33.
CORT News
One Rare Disease Biotech Posts 97% Margins but the Faster Growing Rival Just Turned Its First Profit Quick Read Corcept generates 97.8% gross margins but burns...
In December 2025, Corcept Therapeutics disclosed that the FDA issued a Complete Response Letter for its relacorilant NDA in hypertension secondary to hypercorti...
